Transfection Technologies Market 2022 | Growing Transfection Reagent and Equipment segment

According to Precision Business Insights (PBI), the latest report, the transfection technologies market is expected to be worth USD 1023.8 million in 2022, growing at an 8.9% CAGR from 2022 to 2028. The primary driver of the expansion of the global transfection technologies market includes advances in cell research technologies and therapeutic deliveries, a rise in funding for research and development in transfection technology by government and private firms, the prevalence of cancer, obesity, and various chronic lifestyle diseases, rise in research of cell-based therapies.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/transfection-technologies-market/

Reagent Segment to Dominate the Transfection technologies Market:
The reagent segment is expected to account for a larger revenue share in the global transfection technologies market, with a value share worldwide. Among the product type, the reagents segment dominated the transfection market and is expected to grow at considerably in the upcoming years. The global key market players are influencing the market growth by expanding their reagents portfolio. They are offering reagents at a comparatively low cost which will drive the reagent segment in the transfection technologies market.

Asia Pacific Transfection Technologies Market:
The Asia Pacific market is expected to increase in the global transfection technologies market over the forecast period. It is projected to grow at a significant CAGR in the coming years due to the growing patient pool and untapped market potential, along with the growing healthcare expenditure. It will establish international manufacturers in the section of transfection reagents and equipment. However, active government initiatives and funding will supplement the growth of the global transfection technologies market. North America held a considerable market share in 2021 worldwide. The region is expected to hold the position during the forecast period owing to well-established global vital players and robust funding in the research and development sector.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=56908

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players:
The global transfection technologies market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region. For instance, In Mar 2022, Thermo Fisher Scientific launched a new large-volume electroporation system. The system's goal is to allow cell therapy developers to move more easily from clinical development to commercial manufacturing. In Mar 2021, Lonza launched the next generation of its popular nucleofector platform, the most effective non-viral cell transfection method, which can be used even for hard-to-transfect cells, such as primary cells and pluripotent stem cells.

The Transfection Technologies market is segmented based on product type, transfection method, application, end-user, and geography.
Based on the product type, the market is segmented into the following:
• Reagent
• Instrument
• Others

Based on the transfection method, the market is segmented into the following:
• Reagent-Based Method
• Instrument-Based Method

Based on the application, the market is segmented into the following:
• Therapeutic Delivery
• Bio-Medical Research
• Protein Production
• Others

Based on the end user, the market is segmented into the following:
• Research Centers and Academic Institutes
• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Others

Based on geography, the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

Request Methodology: https://precisionbusinessinsights.com/request-methodology?product_id=56908

Key players' profiles in the transfection technologies market report are Bio-RAD Laboratories, Lonza Group AG, Maxcyte, Mirus Bio, Polyplus Transfection, Promega Corporation, Thermo Fisher Scientific, Roche, Sigma Aldrich, and Synthego.

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.